Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
|Articles|April 1, 2004
- Volume 0 0
TampAlerT
Advertisement
TampAlerT, manufactured by Medi- Dose/EPS, Inc (Ivyland, Pa), is a unique system that allows practitioners to package liquids, solids, or powders in unit doses with tamper-evident seals. TampAlerT is perfect for legend drugs and controlled substances, inpatient, or afterhours dispensing. It is available in vial sizes from 15 mL to 120 mL in natural or white ultraviolet-inhibitant polyethylene with regular or child-resistant caps. For more information: 888-TAMPALERT or 800-523-8966 www.medi-dose.com
Articles in this issue
over 22 years ago
RxPRODUCT NEWS PROFILE: Caduetover 22 years ago
COMPOUNDING HOTLINEover 22 years ago
Case Studiesover 22 years ago
Buddies Are Good for the Heartover 22 years ago
Low-Fat Diet Shows Promise for Prostate Cancerover 22 years ago
Rage Is Connected to Stroke Riskover 22 years ago
InnoLetover 22 years ago
Colace/Peri-Colaceover 22 years ago
Low Testosterone Is Linked with Alzheimer's Diseaseover 22 years ago
Wound Care in an Aging Population: Special ConsiderationsAdvertisement
Related to this article
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
5